Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

Oracle has fixed a zero-day vulnerability in one of its flagship business software products that a hacking group is currently abusing to steal personal information about corporate executives. In a ...

Oracle has linked an ongoing extortion campaign claimed by the Clop ransomware gang to E-Business Suite (EBS) vulnerabilities that were patched in July 2025. While the company has yet to attribute the ...

Oracle is reportedly looking to raise funds just weeks after the company inked a historic AI infrastructure deal with OpenAI. Cloud infrastructure giant Oracle is looking to raise $15 billion through ...

Oracle is set to transform into a top-tier cloud infrastructure player after securing a $300 billion, five-year deal with OpenAI. The "Stargate" project will see ORCL deliver massive AI data center ...

On Monday, September 22, Oracle's stock surged over 6% following a significant leadership change. The company announced that CEO Safra Catz will transition to Executive Vice Chair, and the CEO role ...

In this article, we will be taking a look at the Top 10 AI-Powered Biotech Stocks to Buy Now. Recursion Pharmaceuticals, Inc. is one of them. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), a ...

Oracle's stock surged 36% after reporting record future revenue obligations. Jefferies sees more upside, lifting its stock price target to $360 on cloud and AI growth. Analysts point to Oracle's ...